Identification of novel genes that co-cluster with estrogen receptor alpha in breast tumor biopsy specimens, using a large-scale real-time reverse transcription-PCR approach

Endocrine-Related Cancer

Volumn 13, Issue 4, 2006, Pages 1109-1120

  Tozlu, S ^a,b   Girault, I ^a,b   Vacher, S ^a,b   Vendrell, J ^c   Andrieu, C ^a,b   Spyratos, F ^a,b   Cohen, P ^c   Lidereau, R ^a,b   Bieche, I ^a,b  

^a CENTRE RENÉ HUGUENIN   (France)

^b INSERM   (France)

^c CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CARRIER PROTEIN; CLUSTERIN; CYCLIN D1; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 4; ESTROGEN RECEPTOR ALPHA; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 2; GLYCOPROTEIN; GLYCOPROTEIN GP 130; HEPATOCYTE NUCLEAR FACTOR 3ALPHA; HEPSIN; MEMBRANE PROTEIN; MESSENGER RNA; PROTEIN BCL 2; PROTEIN MYB; PROTEIN PGR; PROTEIN PS2; PROTEIN RET; PROTEIN SEMA3B; PROTEIN SLC39A6; PROTEIN STC2; PROTEIN TFF1; PROTEIN TFF3; TRANSCRIPTION FACTOR GATA 3; TUMOR PROTEIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASCULOTROPIN RECEPTOR 1; X BOX BINDING PROTEIN 1;

APOPTOSIS; ARTICLE; BREAST CARCINOMA; CANCER SCREENING; CELL CULTURE; CONTROLLED STUDY; DNA MICROARRAY; GENE CLUSTER; GENE CONTROL; GENE IDENTIFICATION; GENETIC CODE; GENETIC SELECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TUMOR BIOPSY;

BIOPSY; BREAST NEOPLASMS; ESTROGEN RECEPTOR ALPHA; ESTROGENS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM PROTEINS; NEOPLASMS, HORMONE-DEPENDENT; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; TUMOR CELLS, CULTURED;

EID: 33846815516     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/erc.1.01120     Document Type: Article

References (35)

1. Ashkenazi A 2000 Targeting death and decoy receptors of the tumour-necrosis factor superfamily. Nature Reviews Cancer 2 420-430.
2. Bertucci F, Nasser V, Granjeaud S, Eisinger F, Adelaïde J, Tagett R, Loriod B, Giaconia A, Benziane A, Devilard E et al. 2002 Gene expression profiles of poor-prognosis primary breast cancer correlate with survival. Human Molecular Genetics 11 863-872.
3. Bieche I, Onody P, Laurendeau I, Olivi M, Vidaud D, Lidereau R & Vidaud M 1999 Real-time reverse transcription-PCR assay for future management of ERBB2-based clinical applications. Clinical Chemistry 45 1148-1156.
4. Bieche I, Parfait B, Le Doussal V, Olivi M, Rio MC, Lidereau R & Vidaud M 2001a Identification of CGA as a novel estrogen receptor-responsive gene in breast cancer: an outstanding candidate marker to predict the response to endocrine therapy. Cancer Research 61 1652-1658.
5. Bieche I, Parfait B, Nogues C, Andrieu C, Vidaud D, Spyratos F, Lidereau R & Vidaud M 2001b The CGA gene as new predictor of the response to endocrine therapy in ERalpha-positive postmenopausal breast cancer patients. Oncogene 20 6955-6959.
6. Bieche I, Parfait B, Laurendeau I, Girault I, Girault M & Lidereau R 2001c Quantification of estrogen receptor alpha and beta expression in sporadic breast cancer. Oncogene 20 8109-8115.
7. Bieche I, Lerebours F, Tozlu S, Espie M, Marty M & Lidereau R 2004a Molecular profiling of inflammatory breast cancer: identification of a poor-prognosis gene expression signature. Clinical Cancer Research 10 6789-6795.
8. Bieche I, Girault I, Urbain E, Tozlu S & Lidereau R 2004b Relationship between intratumoral expression of genes coding for xenobiotic-metabolizing enzymes and benefit from adjuvant tamoxifen in estrogen receptor alpha-positive postmenopausal breast carcinoma. Breast Cancer Research 6 R252-R263.
9. Dangles V, Lazar V, Validire P, Richon S, Wertheimer M, Laville V, Janneau JL, Barrois M, Bovin C, Poynard T et al. 2002 Gene expression profiles of bladder cancers: evidence for a striking effect of in vitro cell models on gene patterns. British Journal of Cancer 86 1283-1289.
10. DeRisi J, Penland L, Brown PO, Bittner ML, Meltzer PS, Ray M, Chen Y, Su YA & Trent JM 1996 Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nature Genetics 14 457-460.
11. Ding L, Yan J, Zhu J, Zhong H, Lu Q, Wang Z, Huang C & Ye Q 2003 Ligand-independent activation of estrogen receptor alpha by XBP-1. Nucleic Acids Research 31 5266-5274.
12. Frasor J, Danes JM, Komm B, Chang KCN, Lyttle CR & Katzenellenbogen BS 2003 Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype. Endocrinology 144 4562-4574.
13. Fridman JS & Lowe SW 2003 Control of apoptosis by p53. Oncogene 22 9030-9040.
14. Grant SL, Hammacher A, Douglas AM, Goss GA, Mansfield RK, Heath JK & Begley CG 2002 An unexpected biochemical and functional interaction between gp130 and the EGF receptor family in breast cancer cells. Oncogene 21 460-474.
15. Gruvberger S, Ringner M, Chen Y, Panavally S, Saal LH, Borg A, Fernö M, Peterson C & Meltzer PS 2001 Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. Cancer Research 61 5979-5984.
16. Hanley J & McNeil B 1982 The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143 29-36.
17. Kishimoto T, Taga T & Akira S 1994 Cytokine signal transduction. Cell 76 253-262.
18. Latil A, Bieche I, Chene L, Laurendeau I, Berthon P, Cussenot O & Vidaud M 2003 A four gene expression model predicts recurrence in patients with clinically localized prostate cancer. Clinical Cancer Research 9 5477-5485.
19. Mann H & Whitney D 1947 On a test of whether one of two random variables is stochastically larger than the other. Annals of Mathematical Statistics 18 50-60.
20. McDonnell DP & Norris JD 2002 Connections and regulation of the human estrogen receptor. Science 296 1642-1644.
21. Melino G, Laurenzi V & Vousden KH 2002 p73: Friend or foe in tumorigenesis. Nature Reviews Cancer 2 605-615.
22. Ngwenya S & Safe S 2003 Cell context-dependent differences in the induction of E2F-1 gene expression by 17 Beta-estradiol in MCF-7 and ZR-75 cells. Endocrinology 144 1675-1685.
23. Paradis V, Bieche I, Dargere D, Laurendeau I, Bioulac-Sage P, Degott C, Belghiti J, Vidaud M & Bedossa P 2003 Molecular profiling of hepatocellular carcinomas (HCC) using a large scale real-time RT-PCR approach: determination of a molecular diagnostic index. American Journal of Pathology 163 733-741.
24. Perou CM, Sorlie T, Eisen MB, Van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA et al. 2000 Molecular portraits of human breast tumours. Nature 406 747-752.
25. Pike M, Spicer D, Dahmoush L & Press M 1993 Estrogens, progesterones, normal breast cell proliferation, and breast cancer risk. Epidemiologic Reviews 15 17-35.
26. Prall O, Sarcevic B, Musgrove E, Watts C & Sutherland R 1997 Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2. Journal of Biological Chemistry 272 10882-10894.
27. Sabbah M, Courilleau D, Mester J & Redeuilh G 1999 Estrogen induction of the cyclin D1 promoter: involvement of a cAMP response-like element. PNAS 96 11217-11222.
28. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, Van De Rijn M, Jeffrey SS et al. 2001 Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. PNAS 98 10869-10874.
29. Soulez M & Parker MG 2001 Identification of novel oestrogen receptor target genes in human ZR75-1 breast cancer cells by expression profiling. Journal of Molecular Endocrinology 27 259-274.
30. van't Veer LJ, Dai H, Van De Vijver MJ, He YD, Hart AAM, Mao M, Peterse HL, Van Der Kooy K, Marton MJ, Witteveen AT et al. 2002 Gene expression profiling predicts clinical outcome of breast cancer. Nature 415 530-536.
31. Vendrell JA, Magnino F, Danis E, Duchesne MJ, Pinloche S, Pons M, Birnbaum D, Nguyen C, Theillet C & Cohen PA 2004 Estrogen regulation in human breast cancer cells of new downstream gene targets involved in estrogen metabolism, cell proliferation and cell transformation. Journal of Molecular Endocrinology 32 397-414.
32. Vendrell JA, Bieche I, Desmetz C, Badia E, Tozlu S, Nguyen C, Nicolas JC, Lidereau R & Cohen PA 2005 Molecular changes associated with the agonist activity of hydroxytamoxifen and the hyper-response to estradiol in hydroxytamoxifen-resistant breast cancer cell lines. Endocrine-Related Cancer 12 75-92.
33. Welsh JB, Sapinoso LM, Su AI, Kern SG, Wang-Rodriguez J, Moskaluk CA, Frierson HF & Hampton GM 2001 Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. Cancer Research 61 5974-5978.
34. West M, Blanchette C, Dressman H, Huang E, Ishida S, Spang R, Zuzan H, Olson JA, Marks JR & Nevins JR 2001 Predicting the clinical status of human breast cancer by using gene expression profiles. PNAS 98 11462-11467.
35. Zwijsen RM, Buckle RS, Hijmans EM, Loomans CJ & Bernards R 1998 Ligand-independent recruitment of steroid receptor coactivators to estrogen receptor by cyclin D1. Genes & Development 12 3488-3498.